Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004760637 | SCV005369083 | uncertain significance | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not located in one of the three hot-spot regions of the RYR2 gene, where the majority of pathogenic missense variants occur (Medeiros-Domingo et al., 2009) |
Agnes Ginges Centre for Molecular Cardiology, |
RCV000584816 | SCV000692520 | uncertain significance | Brugada syndrome | 2020-04-07 | no assertion criteria provided | research | The RYR2 Asp1412Gly is a novel variant. It is absent from the Genome Aggregation Database (http://gnomad.broadinstitute.org/). We identified the RYR2 Asp1412Gly variant in a proband presenting with cardiac arrest, who was subsequently diagnosed with Brugada Syndrome (type 1 ECG). The proband has no family history of disease or SCD. Computational tools SIFT and MutationTaster predict this variant to be "deleterious" and "disease-causing" respectively, however PolyPhen-2 predicts the variant to be "benign". Based on the limited information available and rarity in general populations, we classify RYR2 Asp1412Gly as a variant of "uncertain significance". |